NANOG and neoplasm: Similarly, TAp73 is a known tumor suppressor in other cancers and its downregulation has been linked to increased activity of the NF-κB pathway in breast cancer as well as increased stem factor expression of Oct4, nanog and SOX2 in carcinoma-like stem cells [75].